Journal of Clinical Oncology, Vol 1, 204-207, Copyright © 1983 by American Society of Clinical Oncology

ARTICLES

Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy

WP Vaughan, JE Karp and PJ Burke

Eleven consecutive patients with acute myelocytic leukemia occurring as a second malignancy were treated with high-dose, timed, sequential chemotherapy. Eight of the patients were felt to have "secondary" acute leukemia because they had received an alkylating agent or radiation therapy. The other three patients were considered controls. Despite a median age of 65, four of the eight secondary leukemia patients achieved complete remission with this regimen. One of the three control patients also achieved complete remission. This remission rate and duration are comparable to what was achieved with this treatment of "primary" acute myelocytic leukemia during the same period of time. These results suggest that patients with leukemia occurring after an alkylating agent or radiation therapy are not at especially high risk if treated aggressively.

Related Article

• The Long Road to a Cure for Acute Myelocytic Leukemia: From Intensity to Specificity
  William P. Vaughan and Judith E. Karp
  JCO 2008 26: 3475-3477 [Full Text]

This article has been cited by other articles:

				W. P. Vaughan and J. E. Karp The Long Road to a Cure for Acute Myelocytic Leukemia: From Intensity to Specificity J. Clin. Oncol., July 20, 2008; 26(21): 3475 - 3477. [Full Text] [PDF]

				L. Pagano, A. Pulsoni, M. Vignetti, M. E. Tosti, P. Falcucci, P. Fazi, L. Fianchi, A. Levis, A. Bosi, E. Angelucci, et al. Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials Ann. Onc., February 1, 2005; 16(2): 228 - 233. [Abstract] [Full Text] [PDF]